|
|
|
Sunday, March 8, 2009 — 1:30 p.m.
|
- The Role of Molecular Genetics and Cytogenetics in Tumors of the Soft Tissue and Bone
|
|
Moderator:
|
Angelo P. Dei Tos, General Hospital of Treviso, Treviso, Italy
|
| Opening Remarks - Angelo P. Dei Tos, General Hospital of Treviso, Treviso, Italy |
| Using Signaling Pathways to Identify Targets in Soft Tissue Sarcomas - Jonathan Fletcher, Brigham and Woman's University, Boston, MA |
| Patterns of Resistance in GIST: Implications for Genetic Testing and Therapeutics - Christina R. Antonescu, Memorial Sloan-Kettering Cancer Center, New York, NY |
| Clinical Applications of Gene Expression Profiling in Soft Tissue Tumors - Robert B. West, Stanford University, Stanford, CA |
| Application of FISH in Soft Tissue Sarcoma Diagnosis - Andre M. Oliveira, Mayo Clinic, Rochester, MN |
| Clinical Relevance of Molecular Genetics in Bone Tumors - Pancras C. W. Hogendoorn, Leiden University Medical Center, Leiden, The Netherlands |
| Prognostic Relevance of Molecular Genetics in Soft Tissue Tumors - Poul H. Sorensen, Women's and Children's Hospital, Vancouver, Canada |
| Conclusive Remarks - Christopher D. M. Fletcher, Brigham and Woman's Hospital, Boston, MA |
|
|
|